The secretary of biotechnology development headquarter stated: the best type of support of new companies is implementing the venture capital model.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, Mostafa Ghanei, the secretary of biotechnology development headquarter, expressing during a joint meeting with the general director of food and drug administration: “planning for acquiring 3% of the share of the global biotechnology market”, “policy-making, strategic planning, and evaluation of progress of biotechnology in the country”, “national coordination and synergy of resources and facilities of the country for wealth creation from biotechnology”, “helping the improvement of the science and technology level to acquire the first regional position and a worthy global contribution” are among the goals for biotechnology development in the headquarter.

Ghanei also asserted: these companies are at the forefront of their economic growth and development by investors who, with their careful appraisal, compensate for the gaps in capital and the lack of liquidity of entrepreneurial companies, and are placed in their shareholder group.

According to Ghanei, the headquarters play an important role as a venture capitalist with active management and planning in developing strategic models, business development and increasing value added. The prosperity and development of risky investment activities is the driving force behind the growth of new products and innovation in the field of technology.

Secretary of the biotechnology development headquarter continued: by this investment method, the new companies can monitor their activities more creatively and safely and achieve development and progress.